Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells

Toll-like receptor-9 triggering modulates expression of α-4 integrin on human B lymphocytes and their adhesion to extracellular matrix proteins

(2011) Jahangir Abdi et al.   EXPERIMENTAL HEMATOLOGY

The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts

(2010) Chih-Hsin Tang et al.   ARTHRITIS AND RHEUMATISM

Lipoteichoic acid enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, PKCδ and c-Src dependent pathways

(2010) Chih-Hsin Tang et al.   BIOCHEMICAL PHARMACOLOGY

Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-κB

(2010) Yang Xu et al.   BRITISH JOURNAL OF HAEMATOLOGY

Toll-like receptors: Expression and involvement in Multiple Myeloma

(2010) David Chiron et al.   LEUKEMIA RESEARCH

RITA Inhibits Multiple Myeloma Cell Growth through Induction of p53-Mediated Caspase-Dependent Apoptosis and Synergistically Enhances Nutlin-Induced Cytotoxic Responses

(2010) M. N. Saha et al.   MOLECULAR CANCER THERAPEUTICS

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

Cross talk between stimulated NF-κB and the tumor suppressor p53

(2010) G Schneider et al.   ONCOGENE

Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma

(2009) L. Chen et al.   BLOOD

 1 Integrin Adhesion Enhances IL-6-Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation

(2009) K. H. Shain et al.   CANCER RESEARCH

Crosstalk between p53 and nuclear factor-κB systems: pro- and anti-apoptotic functions of NF-κB

(2009) K. Puszynski et al.   IET Systems Biology

TLR3 Ligand Induces NF- B Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-  Production

(2009) D. Chiron et al.   JOURNAL OF IMMUNOLOGY

Environmental-mediated drug resistance: a target for multiple myeloma therapy

(2009) Kenneth H Shain et al.   Expert Review of Hematology

Toll-like receptors: lessons to learn from normal and malignant human B cells

(2008) D. Chiron et al.   BLOOD

The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance

(2008) M. B. Meads et al.   CLINICAL CANCER RESEARCH

Bone marrow microenvironment and the identification of new targets for myeloma therapy

(2008) K Podar et al.   LEUKEMIA

Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma

(2008) K Hatano et al.   ONCOGENE

PCAF is an HIF-1α cofactor that regulates p53 transcriptional activity in hypoxia

(2008) G Xenaki et al.   ONCOGENE

The BCL-2 protein family: opposing activities that mediate cell death

(2007) Richard J. Youle et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY